Current status of antiviral chemotherapy.
D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use; D004660:Encephalitis / Q000188:drug therapy / Q000209:etiology; D006561:Herpes Simplex / Q000188:drug therapy; D006562:Herpes Zoster / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007065:Idoxuridine / Q000494:pharmacology / Q000627:therapeutic use; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D007251:Influenza, Human / Q000188:drug therapy; D007635:Keratitis, Dendritic / Q000188:drug therapy; D008720:Methisazone / Q000627:therapeutic use; D014271:Trifluridine / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use
D000998:Antiviral Agents; D003561:Cytarabine; D000547:Amantadine; D014740:Vidarabine; D008720:Methisazone; D007065:Idoxuridine; D014271:Trifluridine